Technical Eye on Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) for the period of 9-Day stands at 44.46% while the stochastic %D for the same period stands at 51.69%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)’s 20-Day Bollinger Band indicates “Hold”.

About Company

CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer.

Previous Day Activity Analysis

On the last trading day, Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) opened the session at $1.9 and after going up 6.42% closed at $1.99. The stock gained 0.09 points in the last trade.

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)’s stock fluctuated in the range of $1.88 and $2.07 during the previous active session. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) traded with the volume of 1.33 Million with average volume of 751.98 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 3.74 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.14 and 56.86 respectively.

Currently the Insider Ownership of the shares of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) is at 19% and the shares outstanding are 10.7 Million.

Important Ratio Analysis

Some important ratios to consider here for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) are discussed below:

Dividend yield of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 42.59 and 0.76 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 1.57 and 0 correspondingly.

The Quick Ratio of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) stands at 3.7 while the Current Ratio depicts the value of 3.7.

Return on Assets ROA of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) is at -51.6% whereas, Return on Equity ROE and Return of Investment ROI of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) stand at -69.9% and -85.1% respectively.

Stock Performance Analysis

The stock performance of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) on the basis of 5 day trade show the dip of -0.5% whereas, the monthly performance of the stock shows increase of 13.07%.

The quarterly performance of the stock remained in red zone with the value of -35.6% while six month performance of the shares of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) remained bearish with the count of -65.33%.

The yearly and YTD performance of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) remained down at -62.1% and -62.38% respectively.